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Abstract The study addressed the functional link between
remodelling of the actomyosin cytoskeleton in pancreatic L-cells
and the regulation of insulin secretion. Confocal microscopy
revealed that myosin heavy chain (MHC) IIA co-localized very
well with filamentous (F)-actin in RINm5F cells but MHCIIB
did not. Subcellular localization of MHCIIB was not altered by
stimulation with 30 mM KCl (which evokes Ca2+-dependent
insulin secretion). In contrast MHCIIA redistributed in a manner
similar to F-actin, especially towards the apical surface, but also
away from peripheral regions towards cell contact points on the
basal surface. Finally, Ca2+-dependent insulin secretion was
inhibited by stabilization of actin filaments with jasplakinolide.
The results support a role for the MHCIIA/actin cytoskeleton in
regulating insulin secretion. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
A rise in the cytosolic free Ca2 concentration is a key
event in the stimulation of insulin secretion [1^3]. The subse-
quent activation of Ca2-dependent protein kinases is thought
to be crucial to the secretory process but the substrates of
these protein kinases are very poorly characterized [4^6].
However we have recently identi¢ed myosin II heavy chain
(MHC) as one such substrate in pancreatic islets and insulin-
secreting RINm5F cells [7,8] which was phosphorylated
chie£y on threonine residues at times preceding the peak of
secretion [7]. Whereas both MHCIIA and MHCIIB were
present in L-cells, threonine phosphorylation occurred mainly
on MHCIIA. Threonine phosphorylation of MHC was sub-
sequently shown to correlate with dissolution of the cortical
actin web of neuronal cells [9]. This is consistent with a postu-
lated requirement for disruption of a cytoskeletal meshwork
in order to allow ¢nal access of secretory vesicles to the plas-
ma membrane [9^13]. However evidence in support of this
hypothesis for insulin secretion is limited to observations
that agents which disrupt actin also enhance secretion [14^
17]. The function of myosin in this context is poorly under-
stood in L-cells, because of a prior emphasis on myosin’s
other role: as a motor protein driving transport of secretory
granules [16,18]. Motor function is chie£y controlled by phos-
phorylation of regulatory light chains (RLCs) which are also
present with MHC in the myosin II complex [19,20]. However
we have recently shown that phosphorylation of RLCs in L-
cells is constitutive and (in contrast to MHC phosphorylation)
not further augmented by insulin secretagogues [8].
The aim of the current study was to reassess the involve-
ment of the actin cytoskeleton in the secretory response in
pancreatic L-cells. Our results indicate that cytoskeletal re-
modelling is required for insulin secretion, and are consistent
with a model in which phosphorylation of MHCIIA facilitates
granular access to the plasma membrane.
2. Materials and methods
RINm5F cells were maintained in RPMI 1640 as adherent mono-
layers [7]. Studies of insulin secretion were exactly as described [8]
except that cells were cultured overnight in 24-well plates at 106
cells/well. Experimental incubations were in modi¢ed Krebs^Ringer
bicarbonate bu¡er (KRB) containing 5 mM NaHCO3, 1 mM CaCl2,
2.8 mM glucose, 10 mM HEPES (pH 7.4) and 0.5% (w/v) bovine
serum albumin (BSA). Jasplakinolide (Molecular Probes) was dis-
solved in dimethyl sulfoxide and this solvent was also added to con-
trol incubations (0.1% ¢nal). Insulin secreted into the medium during
a 15 min incubation was measured by radioimmunoassay. For con-
focal microscopy, cells were cultured overnight at 0.1^0.15U106cells/
0.4 ml/well in 8-well chamber slides (Nalge-Nunc International). Ex-
perimental additions were made in 0.4 ml KRB at 37‡C for 5 min.
Cells were ¢xed with 4% paraformaldehyde/phosphate-bu¡ered saline
(PBS)/0.1% (v/v) Triton X-100 at room temperature for 30 min, and
then washed twice in PBS/0.05% (v/v) Tween 20 and blocked for V30
min in PBS/1% BSA. Myosin was detected using primary antisera
diluted 1:20, with a £uorescein isothiocyanate (FITC)-conjugated sec-
ondary antibody (Amersham). These primary antisera were raised
against the C-termini of rat non-muscle MHCIIA and MHCIIB, re-
spectively [21], and like those made to corresponding regions of Xen-
opus and human non-muscle MHC isoforms, and which have been
extensively characterized [22,23], their speci¢city has been con¢rmed
previously by immunoblotting [7,21]. Cells were then mounted in 90%
(v/v) glycerol, 10% (v/v) PBS containing 1 mg/ml p-phenylenediamine.
No immuno£uorescence was observed in ¢xed cells incubated with the
FITC-conjugated secondary antibody alone. Filamentous (F)-actin
was detected using Texas Red-linked phalloidin diluted 1:200 (Sigma)
and, in co-localization studies, this was added after the myosin and
the FITC-conjugated secondary antibodies. Cells were visualized at
60U magni¢cation using a Sarastro 2000 CLSM laser scanning con-
focal microscope from Molecular Dynamics. Optical sections were
taken at 0.39 WM intervals.
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3. Results
The subcellular distribution of MHCIIA, MHCIIB and F-
actin in RINm5F cells was investigated using confocal micros-
copy. Composite images (Fig. 1A,B) revealed that although
both MHC isozymes were fairly widely distributed, MHCIIA
was concentrated in cell peripheries, whereas these areas were
largely devoid of MHCIIB. These di¡erences are even more
Fig. 1. Subcellular localization of myosin IIA/IIB and co-localization with F-actin. RINm5F cells were ¢xed and exposed to speci¢c myosin
IIA (A and C) or myosin IIB antibodies (B and D) and an FITC-conjugated secondary antibody. Confocal microscopy was undertaken at
60U magni¢cation. (A and B) Horizontal (z-) sections were made through the cells at a step size of V0.39 Wm and the images are presented
as a projection series. The arrows highlight di¡erential distribution of myosin IIA and IIB in leading edges. (C and D) Cells were also labelled
with Texas Red-conjugated phalloidin to visualize F-actin. The images presented are single (V0.39 Wm) sections of the basal region of the
cells.
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apparent on the basal cell surface (Fig. 1C,D) where F-actin
co-localizes with MHCIIA, but not MHCIIB, at cell periph-
eries and regions of cell to cell contact. Indeed there appeared
to be very little co-localization of F-actin and MHCIIB at all
in these cells.
Fig. 2A shows a more complete analysis of the experiments
from which the composite image shown in Fig. 1C was taken.
Distributions of MHCIIA and F-actin are shown individually
(as well as merged) on both basal and apical surfaces of un-
stimulated cells. On the basal surface (panel d) F-actin was
concentrated at peripheries and areas of cell contact, but was
more di¡use on the apical cell surfaces (panel a). MHCIIA
staining (panels b and e) was generally similar to that of actin,
as con¢rmed by the merged images (panels c and f) most
obviously on the basal surface, but also in sub-membrane
regions on the apical surface. Upon stimulation with KCl
(Fig. 2B) there was a marked concentration of myosin (cf.
panels b and h) and especially actin (panels a and g) around
the apical surface. Although less extensively investigated, the
nutrient stimulus glyceraldehyde (10 mM) induced similar al-
terations (not shown). Yellow areas of merged £uorescence
con¢rm a degree of co-localization of MHCIIA and actin in
these areas, but some regions of red signal also suggest that
co-localization is not uniform (panel i). Cell stimulation also
Fig. 2. Myosin IIA and F-actin co-localization. Unstimulated (A) or stimulated (B) were dual labelled to visualize F-actin (red staining, left
panels) and myosin IIA isoform (green staining, middle panels). Overlap of the £uorophores appears yellow in the merged images (right pan-
els). The images presented (60U magni¢cation) are single (V0.39 Wm) sections of the apical and basal region of the cells. The arrows highlight
the presence of F-actin and myosin IIA in leading edges on the basal surface.
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caused a subtle consolidation of both actin and myosin in the
areas of cell to cell contacts, and away from the peripheries,
on the basal surface. This is most evident in the merged im-
ages (cf. panels f and l). Note also that the strong co-local-
ization of MHCIIA and F-actin on this surface is retained
upon cellular stimulation (panel l).
Corresponding analysis of MHCIIB distribution (Fig. 3A)
revealed poor co-localization with F-actin on both apical and
basal surfaces. Stimulation with KCl (Fig. 3B) caused a redis-
tribution of F-actin at the apical surface (panel g) and a con-
centration in areas of cell to cell contacts on the basal surface
(panel j) but this was not accompanied by any discernible
rearrangement of MHCIIB (panels b versus h). Likewise there
was virtually no co-localization of the two proteins at either
surface under stimulated conditions (panels i and l).
The next experiments examined the e¡ect on secretion of
jasplakinolide, which stabilizes actin ¢laments [24]. While not
a¡ecting basal insulin secretion, this compound inhibited by
more than 50% the response to stimulatory KCl concentra-
tions (Fig. 4). As previously documented [24], actin was only
poorly visualized using Texas Red-conjugated phalloidin in
jasplakinolide-treated cells (not shown) since these two agents
compete with each other for binding to F-actin [24]. This
con¢rms that the e¡ects of jasplakinolide on secretion are
Fig. 3. Lack of Myosin IIB and F-actin co-localization. Images (60U magni¢cation) were generated as described in the legend to Fig. 2 except
that middle panels represent staining for myosin IIB. The arrows highlight the presence of F-actin but absence of myosin IIB in leading edges
on the basal surface.
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likely to be due to actin binding in RINm5F cells. Conversely
cytochalasin B, which disrupts actin ¢laments (14^17), en-
hanced basal secretion to a level of approximately 15% of
KCl response (Fig. 4) or more than double basal (not shown).
4. Discussion
This study provides a number of novel observations to sup-
port the hypothesis that F-actin remodelling helps regulate the
release of insulin granules from pancreatic L-cells. Crucially,
we demonstrate for the ¢rst time that F-actin is actually redis-
tributed in these cells in response to a secretory stimulus. This
was not detected in a previous study using £uorescence mi-
croscopy on a hamster insulinoma cell line [17]. By exploiting
the more sensitive technique of confocal microscopy, and by
focusing independently on both apical and basal surfaces
rather than full transmission images, we have now clearly
demonstrated alterations in F-actin staining upon stimulation.
The second novel observation is that jasplakinolide which
prevents F-actin remodelling inhibits stimulated, but not
basal, secretion. This clearly implies that dynamic alterations
in the actin cytoskeleton are actually necessary for a full se-
cretory response, and extends the interpretation of earlier
studies using cytochalasin which suggested that such altera-
tions were su⁄cient to promote secretion [14^17]. This ex-
tended conclusion is also consistent with the recent ¢ndings
that exocytosis in patch-clamped, mouse L-cells was decreased
by inhibition of scinderin, an F-actin severing protein [25].
Our results are therefore broadly consistent with the hy-
pothesis, elucidated using a number of secretory cells [9^13],
that ¢nal access of secretory granules to the plasma membrane
requires dissolution of a de¢ned cortical actin web [9^13].
However the cortical actin web of RINm5F cells, as visualized
in the current study, is not as well-de¢ned as in some other
secretory cell types, nor is its dissolution as pronounced on
stimulation. This does not preclude involvement of the cyto-
skeletal changes described here in controlling insulin secretion,
since granular access could equally (and more e⁄ciently) be
regulated by a more subtle remodelling of cytoskeletal com-
plexes, rather than their complete fragmentation. Examples of
this might include formation of gaps in the actin meshwork
and/or a retraction of the cell web away from exocytotic sites.
However this would be di⁄cult to visualize unless more spe-
ci¢c protein markers for such cytoskeletal ‘hot-spots’ became
available. In this context it should also be stressed that phal-
loidin does not stain all F-actin pools [26] and that perhaps a
functional cortical actin web might be better detected in the
future using antisera to speci¢c actin isoforms, or other actin
binding proteins [26,27].
The demonstration that MHCIIA and MHCIIB are di¡er-
entially localized in pancreatic L-cells is another novel ¢nding.
Furthermore the observations that MHCIIB was di¡usely ex-
pressed, co-localized poorly with phalloidin-stained actin, and
was not apparently redistributed upon cellular stimulation,
render it an unlikely candidate for controlling secretion. On
the other hand MHCIIA exhibited a more discrete localiza-
tion, especially on the basal cell surface where it was highly
co-localized with F-actin on cell peripheries. Upon stimula-
tion, MHCIIA accompanied the redistribution of F-actin that
occurred on both the basal and apical cell surfaces. These
¢ndings are of potential interest given that Ca2-dependent
stimulation of pancreatic L-cells results in a more pronounced
threonine phosphorylation of MHCIIA than MHCIIB [7,28].
Although we have no direct evidence of a causal link between
phosphorylation and subcellular redistribution of MHCIIA-
associated F-actin, such a link would at least be consistent
with the strong correlation between MHC threonine phos-
phorylation and cytoskeletal remodelling found in neuronal
N1E-115 cells [10]. A role for MHC phosphorylation in con-
trolling the cross-linking of actomyosin ¢laments is also di-
rectly supported by experiments with invertebrate models
[19,29].
In conclusion we have demonstrated that Ca2-dependent
insulin secretion is accompanied by morphological changes in
F-actin distribution in RINm5F cells, and that depolymeriza-
tion of actin ¢laments is necessary for secretion to proceed. In
addition there are stimulus-dependent changes in the localiza-
tion of MHCIIA but not MHCIIB. The results are consistent
with the actin/myosin IIA cytoskeleton playing an important
role in the regulation of insulin secretion, potentially in con-
trolling the ¢nal access of secretory granules for docking with
the plasma membrane.
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